Gary Conard Visor
15Patents
7h-index
29Co-inventors
66Inventor score
Filing activity: Oct 14, 1986 → Jul 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8865735B2 | Solid forms of a pharmaceutically active substance | Human Necessities | 53 | Active |
| US4837239A | Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins | Human Necessities | 41 | Expired |
| US9447089B2 | Compositions and uses thereof | Mechanical Engineering; Lighting; Heating | 40 | Active |
| US9663517B2 | Compositions and uses thereof | Mechanical Engineering; Lighting; Heating | 29 | Active |
| US9802932B2 | Solid forms of a compound modulating kinases | Human Necessities | 18 | Active |
| US10435404B2 | Formulations of a compound modulating kinases | Chemistry; Metallurgy | 8 | Active |
| US10189833B2 | Solid forms of a compound modulating kinases | Human Necessities | 8 | Active |
| US10316032B2 | Solid forms of a compound for modulating kinases | Chemistry; Metallurgy | 6 | Active |
| US10584122B2 | Solid forms of a compound modulating kinases | Human Necessities | 5 | Active |
| US10941142B2 | Formulations of a compound modulating kinases | Chemistry; Metallurgy | 3 | Active |
| US8084501B2 | Stable prostaglandin-containing compositions | Human Necessities | 3 | Active |
| US8557814B2 | mTOR inhibitor salt forms | Human Necessities | 3 | Active |
| US10961240B2 | Formulations of a compound modulating kinases | Chemistry; Metallurgy | 3 | Active |
| US11103505B2 | Formulations of a compound modulating kinases | Human Necessities | 1 | Active |
| US8748455B2 | Solid forms of a pharmaceutically active substance | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.